EE260 Cost-Effectiveness of Mixed Maternal RSVpreF/Infant Nirsevimab Immunization Approach vs. Nirsevimab Alone for the Prevention of Respiratory Syncytial Virus in Chile
Abstract
Authors
Rafael Bolaños Juan Francsico Falconi Ahuva Averin Erin Quinn Amy Law Rengina Kefalogianni Diana Mendes